Letter to Merck

Letter to Merck

December 30, 2008 Richard Clark, CEO Merck & Company One Merck Drive  P.O. Box 100 Whitehouse Station, NJ 08889-0100 Dear Mr. Clark, I am writing to you regarding your recent decision to discontinue production and sales of your monovalent measles (Attenuvax) and...